News

May 18, 2018

HD 【Presentation】Financial Results for the Fiscal Year Ended March 31, 2018

May 11, 2018

HD Notice concerning surplus dividends

May 11, 2018

HD Notice concerning the Representative Directors of Meiji Group Companies

May 11, 2018

HD Consolidated Financial Results for the Fiscal Year Ended March 31, 2018

Mar 27, 2018

PHARMA MEIJI AND ARYSTA ENTER INTO LICENSING AGREEMENT CONCERNING NEW INSECTICIDE FLUPYRIMIN IN INDIA

Mar 13, 2018

HD Notice Concerning Signing of the Definitive Agreement with Kaketsuken to acquire shares of a company that will be transferred Kaketsuken's main business in the form of contribution in kind and to make the company a consolidated subsidiary

Feb 7, 2018

HD Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2018

Feb 1, 2018

PHARMA PRIMARY ENDPOINT MET IN PHASE II / III CLINICAL STUDY OF INVESTIGATIONAL PARKINSON'S DISEASE TREATMENT SAFINAMIDE IN JAPAN